End-of-life care for people with sickle cell disease : barriers to and facilitators of high-quality care

Article indépendant

PATEL, Rushil V. | JOHNSTON, Emily E.

End-of-life (EOL) care is a critical part of sickle cell disease (SCD) management. However, barriers to high-quality EOL care remain, including (1) disease-related barriers (prior opioid exposure, risk of vaso-occlusive crises, chronic conditions with conflicting needs, and limitations of receiving disease-directed therapy on hospice); (2) communication-related barriers (challenges of identifying and responding to religious and spiritual concerns, limited health literacy, and previous health care system experience); (3) systemic issues (social determinants of health, structural racism, and mistrust of the medical system). However, palliative care and interdisciplinary collaboration can overcome many of these barriers. In addition, we can improve EOL care by accounting for opioid exposures, multimodal symptom management, and exploring (1) who people want involved in decision-making, (2) the role of religion and spirituality in decision-making, and (3) previous experiences with EOL. Systemic barriers can be addressed through the social determinants of health screening, minimizing financial burdens of care, and building longitudinal relationships with people with SCD. This requires the continued education of SCD providers about primary palliative care and palliative care providers about SCD. With such strategies, high-quality EOL care is possible for this vulnerable population.

http://dx.doi.org/10.1182/hematology.2024000561

Voir la revue «Hematology. American Society of Hematology. Education program, 2024»

Autres numéros de la revue «Hematology. American Society of Hematology. Education program»

Consulter en ligne

Suggestions

Du même auteur

End-of-life care for people with sickle cell ...

Article | PATEL, Rushil V. | Hematology. American Society of Hematology. Education program | n°1 | vol.2024

End-of-life (EOL) care is a critical part of sickle cell disease (SCD) management. However, barriers to high-quality EOL care remain, including (1) disease-related barriers (prior opioid exposure, risk of vaso-occlusive crises, ch...

Serious illness care considerations for Hindu...

Article | PATEL, Rushil V. | JOURNAL OF PALLIATIVE MEDICINE | n°3 | vol.27

Hinduism is a major world religion. The number of Hindus living in the United States is estimated to reach 5 million by 2050; globally, the Hindu population is already around 1.5 billion.1,2 This Fast Fact highlights care consider...

Serious illness care considerations for Hindu...

Article indépendant | PATEL, Rushil V. | JOURNAL OF PALLIATIVE MEDICINE | n°3 | vol.27

Hinduism is a major world religion. The number of Hindus living in the United States is estimated to reach 5 million by 2050; globally, the Hindu population is already around 1.5 billion.1,2 This Fast Fact highlights care consider...

De la même série

Challenges in hospice and end-of-life care in...

Article indépendant | RODENBACH, Rachel | Hematology. American Society of Hematology. Education program | n°1 | vol.2024

Despite promising advances leading to improved survival, many patients with hematologic malignancies end up dying from their underlying disease. Their end-of-life (EOL) care experience is often marked by worsening symptoms, late c...

End-of-life care for people with sickle cell ...

Article indépendant | PATEL, Rushil V. | Hematology. American Society of Hematology. Education program | n°1 | vol.2024

End-of-life (EOL) care is a critical part of sickle cell disease (SCD) management. However, barriers to high-quality EOL care remain, including (1) disease-related barriers (prior opioid exposure, risk of vaso-occlusive crises, ch...

Anticoagulation at the end of life : whether,...

Article indépendant | PARKS, Anna L. | Hematology. American Society of Hematology. Education program | n°1 | vol.2024

Nearly 2 out of 3 patients with venous thromboembolism (VTE) and 1 out of 4 patients with atrial fibrillation (AF) will die within the year. Whether, when, and how to manage anticoagulation at the end of life requires many trade-o...

Chargement des enrichissements...